Idah Mokhele [Researcher - Epidemiology]

Idah Mokhele

Ms Idah Mokhele joined HE2RO on 1 November 2016 as a Research. She holds a BSc degree in Microbiology and Biotechnology from the University Of Cape Town (UCT), and a Masters in Epidemiology and Biostatistics from the University of Witwatersrand (WITS). Prior to joining HE2RO Idah worked for Right to Care; first for a number of years managing donor funded HIV programmes and managing sub-award partner grants. After completing her Masters, she then left grant and programme management to focus on operational research. In this role she was involved providing
research technical assistance to the organisation’s programme staff. She also oversaw studies relating to some of Right to Care’s HIV programmes including cervical cancer screening and Medical Male Circumcision (MMC) programmes. Her research interests include: ART access, Women’s health, HIV and non-communicable diseases, and treatment outcomes in HIV programmes.


  • Rates and predictors of ART refusal under the universal-test-and-treat (UTT) policy in South Africa

    Although almost four of seven million persons living with HIV on antiretroviral therapy (ART), an additional 2.5 million individuals must be initiated on ART to reach the target of initiating 90% of diagnosed HIV positive patients on ART by 2020. However, an estimated 20% of South African patients eligible under CD4<200 eligibility threshold were likely to refuse ART. With the removal of CD4 eligibility thresholds in 2016, it is unclear whether the demand for ART has improved and 
  • Building the Capacity of Lay Health Counsellors to Improve ART Uptake among High CD4 Patients under the “Treat All’ Policy in South Africa

    In September 2016, South Africa began implementing test-and-treat, in which everyone who tests HIV positive is offered antiretroviral therapy (ART), in hopes of attaining the UNAIDS 90-90-90 targets. However the success of the test-and-treat approach depends on early HIV testing and lifelong HIV treatment. In South Africa, lay HIV counselors are the first to introduce ART to newly diagnosed patients. However, most are under-trained with little professional supervision and emotional support and